Bailout glycoprotein IIb/IIIa inhibitors for coronary microvascular obstruction: guideline-indicated, but does harm outweigh benefit?

Latter, Jasmine; McCartney, Peter; Berry, Colin

Latter, Jasmine; McCartney, Peter; Berry, Colin.

Afiliación

Latter J; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, United Kingdom.
McCartney P; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, United Kingdom.
Berry C; British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom.

Eur Heart J ; 2024 Sep 01.

Article en En | MEDLINE | ID: mdl-39217606

Palabras clave

clinical guidelines; clinical trial; glycoprotein IIb/IIIa inhibitor; myocardial infarction; no-reflow; percutaneous coronary intervention

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google